Literature DB >> 1384221

Distribution of cytokeratins, vimentin and desmoplakins in normal renal tissue, renal cell carcinomas and oncocytoma as revealed by immunofluorescence microscopy.

A Beham1, M Ratschek, K Zatloukal, C Schmid, H Denk.   

Abstract

Forty-two renal cell carcinomas, one oncocytoma and normal renal tissue were studied for the presence of cytokeratins and vimentin. The investigations were performed by immunofluorescence microscopy applying a panel of mono- and polyclonal antibodies to intermediate filament proteins. In all tumours except chromophobic renal cell carcinoma (CRCC) and oncocytoma a co-expression of cytokeratins and vimentin could be shown. The intermediate filament expression was often, however, very heterogeneous particularly with respect to the distribution of cytokeratins and vimentin, to the clonality of the antibodies used and to the tumour areas studied. The latter could be impressively demonstrated by examining a whole tumour. In CRCC and oncocytoma all tumour cells expressed cytokeratins and, in addition, single tumour cells also expressed vimentin. In normal renal tissue we could show vimentin-positive epithelia of proximal and distal tubules, which is reported for the first time.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1384221     DOI: 10.1007/bf01611177

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  20 in total

1.  Renal oncocytoma. II. Lectin and immunohistochemical features indicating an origin from the collecting duct.

Authors:  M Ortmann; M Vierbuchen; R Fischer
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1988

2.  Pathology of cytoskeleton of liver cells: demonstration of mallory bodies (alcoholic hyalin) in murine and human hepatocytes by immunofluorescence microscopy using antibodies to cytokeratin polypeptides from hepatocytes.

Authors:  H Denk; W W Franke; B Dragosics; I Zeiler
Journal:  Hepatology       Date:  1981 Jan-Feb       Impact factor: 17.425

3.  Antibodies to different intermediate filament proteins. Cell type-specific markers on paraffin-embedded human tissues.

Authors:  M Altmannsberger; M Osborn; A Schauer; K Weber
Journal:  Lab Invest       Date:  1981-11       Impact factor: 5.662

4.  Expression of intermediate filament proteins in fetal and adult human kidney: modulations of intermediate filament patterns during development and in damaged tissue.

Authors:  R Moll; C Hage; W Thoenes
Journal:  Lab Invest       Date:  1991-07       Impact factor: 5.662

5.  Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics.

Authors:  W Thoenes; S Störkel; H J Rumpelt
Journal:  Pathol Res Pract       Date:  1986-05       Impact factor: 3.250

6.  Distribution of vimentin, cytokeratins, and desmosomal-plaque proteins in human nephroblastoma as revealed by specific antibodies: co-existence of cell groups of different degrees of epithelial differentiation.

Authors:  H Denk; W Weybora; M Ratschek; R Sohar; W W Franke
Journal:  Differentiation       Date:  1985       Impact factor: 3.880

7.  Cellular origin and differentiation of renal carcinomas. A fluorescence microscopic study with kidney-specific antibodies, antiintermediate filament antibodies, and lectins.

Authors:  H Holthöfer; A Miettinen; R Paasivuo; V P Lehto; E Linder; O Alfthan; I Virtanen
Journal:  Lab Invest       Date:  1983-09       Impact factor: 5.662

8.  Histogenesis of renal cell carcinoma and renal oncocytoma. An immunohistochemical study.

Authors:  C Cohen; P A McCue; P B Derose
Journal:  Cancer       Date:  1988-11-01       Impact factor: 6.860

9.  Prognostic significance of vimentin positivity in formalin-fixed renal cell carcinomas.

Authors:  K Donhuijsen; S Schulz
Journal:  Pathol Res Pract       Date:  1989-03       Impact factor: 3.250

10.  Expression of intermediate filament proteins in subtypes of renal cell carcinomas and in renal oncocytomas. Distinction of two classes of renal cell tumors.

Authors:  S Pitz; R Moll; S Störkel; W Thoenes
Journal:  Lab Invest       Date:  1987-06       Impact factor: 5.662

View more
  5 in total

1.  High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma.

Authors:  H Moch; P Schraml; L Bubendorf; M Mirlacher; J Kononen; T Gasser; M J Mihatsch; O P Kallioniemi; G Sauter
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

2.  Pathway signature and cellular differentiation in clear cell renal cell carcinoma.

Authors:  Han W Tun; Laura A Marlow; Christina A von Roemeling; Simon J Cooper; Pamela Kreinest; Kevin Wu; Bruce A Luxon; Mala Sinha; Panos Z Anastasiadis; John A Copland
Journal:  PLoS One       Date:  2010-05-18       Impact factor: 3.240

3.  Establishment and characterization of two divergent cell lines derived from a human chromophobe renal cell carcinoma.

Authors:  C D Gerharz; R Moll; S Störkel; U Ramp; B Hildebrandt; G Molsberger; P Koldovsky; H E Gabbert
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

4.  Vimentin Targeted Nano-gene Carrier for Treatment of Renal Diseases.

Authors:  Ansuja Pulickal Mathew; Saji Uthaman; Eun Hui Bae; Jae Young Lee; In-Kyu Park
Journal:  J Korean Med Sci       Date:  2021-12-20       Impact factor: 2.153

5.  Increased PADI4 expression in blood and tissues of patients with malignant tumors.

Authors:  Xiaotian Chang; Jinxiang Han; Li Pang; Yan Zhao; Yi Yang; Zhonglin Shen
Journal:  BMC Cancer       Date:  2009-01-30       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.